140 related articles for article (PubMed ID: 6183568)
1. Muscarinic cholinergic receptor-mediated activation of phosphodiesterase.
Meeker RB; Harden TK
Mol Pharmacol; 1982 Sep; 22(2):310-9. PubMed ID: 6183568
[No Abstract] [Full Text] [Related]
2. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
Meeker RB; Harden TK
Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
[TBL] [Abstract][Full Text] [Related]
3. Identification of the phosphodiesterase regulated by muscarinic cholinergic receptors of 1321N1 human astrocytoma cells.
Tanner LI; Harden TK; Wells JN; Martin MW
Mol Pharmacol; 1986 May; 29(5):455-60. PubMed ID: 2422535
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cyclic AMP metabolism by muscarinic cholinergic receptors.
Harden TK; Evans T; Hepler JR; Hughes AR; Martin MW; Meeker RB; Smith MM; Tanner LI
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985; 19():207-20. PubMed ID: 2988297
[TBL] [Abstract][Full Text] [Related]
5. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities.
Ashby B
Mol Pharmacol; 1989 Dec; 36(6):866-73. PubMed ID: 2481225
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
Evans T; Smith MM; Tanner LI; Harden TK
Mol Pharmacol; 1984 Nov; 26(3):395-404. PubMed ID: 6092892
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic cholinergic receptors in mouse pituitary tumor cells: prolonged agonist pretreatment decreases receptor content and increases forskolin- and hormone-stimulated cyclic AMP synthesis and adrenocorticotropin secretion.
Heisler S; Desjardins D; Nguyen MH
J Pharmacol Exp Ther; 1985 Jan; 232(1):232-8. PubMed ID: 2981317
[TBL] [Abstract][Full Text] [Related]
8. Alpha adrenergic and cholinergic-muscarinic regulation of adenosine cyclic 3',5'-monophosphate levels in the rat parotid.
Oron Y; Kellogg J; Larner J
Mol Pharmacol; 1978 Nov; 14(6):1018-30. PubMed ID: 32474
[No Abstract] [Full Text] [Related]
9. Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists.
Olianas MC; Onali P; Neff NH; Costa E
Mol Pharmacol; 1983 Mar; 23(2):393-8. PubMed ID: 6188035
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic cholinergic inhibition of cyclic AMP formation and adrenocorticotropin secretion in mouse pituitary tumor cells.
Heisler S; Larose L; Morisset J
Biochem Biophys Res Commun; 1983 Jul; 114(1):289-95. PubMed ID: 6309168
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic cholinergic receptor-mediated attenuation of adenylate cyclase activity in rat heart membranes.
Smith MM; Harden TK
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(2):197-210. PubMed ID: 3998232
[TBL] [Abstract][Full Text] [Related]
12. In vivo regulation of muscarinic cholinergic receptors in embryonic chick brain.
Meyer MR; Gainer MW; Nathanson NM
Mol Pharmacol; 1982 Mar; 21(2):280-6. PubMed ID: 7099136
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of cyclic AMP levels by activation of cyclic nucleotide phosphodiesterases: the example of the dog thyroid.
Dumont JE; Miot F; Erneux C; Couchie D; Cochaux P; Gervy-Decoster C; Van Sande J; Wells JN
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():325-36. PubMed ID: 6202125
[No Abstract] [Full Text] [Related]
14. Muscarinic cholinergic receptors on cultured thyroid cells. I. Biological effect of carbachol and characterization of the receptors.
Champion S; Mauchamp J
Mol Pharmacol; 1982 Jan; 21(1):66-72. PubMed ID: 6290866
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic-dopaminergic synergism on retinal cyclic AMP formation.
Brown JH; Rietow M
Brain Res; 1981 Jun; 215(1-2):388-92. PubMed ID: 6266579
[TBL] [Abstract][Full Text] [Related]
16. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide.
Smith MM; Harden TK
J Pharmacol Exp Ther; 1984 Feb; 228(2):425-33. PubMed ID: 6319678
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of isoproterenol-stimulated tissue cyclic AMP level by cholinergic agonists in rat parotid gland.
Yoshimura K; Nezu E; Yoneyama T
Jpn J Physiol; 1985; 35(5):765-81. PubMed ID: 2416975
[TBL] [Abstract][Full Text] [Related]
18. Treatment of intact hepatocytes with the calcium ionophore A23187 perturbs both the synthesis and the degradation of the second messenger cyclic AMP. Actions on adenylate cyclase and cyclic AMP phosphodiesterase activities.
Irvine FJ; Houslay MD
Biochem Pharmacol; 1988 Jul; 37(14):2773-9. PubMed ID: 2456067
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenergic receptor regulation of a cyclic AMP phosphodiesterase in C6 glioma cells.
Schwartz JP; Onali P
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():195-203. PubMed ID: 6326524
[No Abstract] [Full Text] [Related]
20. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
Miot F; Erneux C; Wells JN; Dumont JE
Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
